Scientists found fewer cancer diagnoses in the U.S. during the first year of the COVID-19 pandemic, per a new study from American Cancer Society. With the largest drop for early stage diagnoses, researchers point to the concurrent decline of elective screenings and care. This led to more late-stage disease, a trend that has been mirrored locally.

The study was published Tuesday in the journal Lancet Oncology.

As the world shut down and hospitals diverted resources to tackle the novel coronavirus, many elective surgeries and preventive screenings were canceled. The study, which looked at more than 2 million adults diagnosed with cancer between 2018 and 2020, found that diagnoses in 2020 dropped by half.

Diagnoses ticked back up by November 2020, the study found, but a greater percentage of those diagnoses were stage IV compared to stages I through III. Patients were identified via the U.S. National Cancer Database, and all cancer types and all 50 states and the District of Columbia were included in the analysis.

Advertise with us

“These updated results for all major cancer types nationwide represent a more comprehensive view and continue to be concerning as decreased screening, as well as delayed and forgone routine check-ups or doctor visits, can lead to underdiagnosis of cancer, especially in early stages, where treatment is most effective,” Xuesong Han, first author on the paper, said in a news release. Ms. Han is the scientific director of health services research at the American Cancer Society.

The trend seems to be consistent with cancer patients in Pittsburgh. Monica Baskin, associate director of community outreach and health equity at UPMC Hillman Cancer Center and a professor of medicine at Pitt School of Medicine, said the study confirmed what experts have already known. Preliminary data analysis from patients diagnosed with cancer in 2020 at any UPMC Hillman Cancer Center — which serves 29 counties in Western Pennsylvania — found a decline in cancer diagnoses, particularly between March and April, said Ms. Baskin. That same trend was also apparent in the fall of 2020.

Dr. David Bartlett, chair of Allegheny Health Network Cancer Institute, said AHN clinics saw a significant drop-off in screenings in 2020. Colonoscopies and mammograms in particular took a hit, and the institution paused its monthly free screening events for one year due to COVID-19.

“We’re back to where we were volume-wise for screenings, but we still need to do better,” he said. “What we should do is learn the lesson and make sure things that impact one aspect of people’s health care don’t impact their ability to get screened.”

In the paper, authors wrote that those most impacted by the trend were Hispanic patients, Asian American and Pacific Islander patients, the uninsured and those on Medicare under the age of 65.

Advertise with us

In Western Pennsylvania, those who are low-income, who live in rural areas and the marginalized are most vulnerable, Ms. Baskin said.

“It’s even more concerning because we have tried to increase our outreach to get these populations to get screened more,” she said. Barriers to getting cancer screenings include a lack of transportation to clinics and potential follow-up appointments, high cost of insurance co-payments or lack of insurance and a lack of providers, specifically a dearth of providers of color.

“Patients like to see providers who look like them,” she said. “We have an opportunity to increase diversity in the biomedical workforce.”

Ruth Etzioni, a biostatistician and a professor in the Public Health Sciences Division at Fred Hutch Cancer Center in Seattle, said the study’s results were “completely unsurprising,” and that the American Cancer Society is justified in being concerned. Ms. Etzioni specializes in early cancer detection and works with the American Cancer Society to develop screening guidelines. She is a Carnegie Mellon University alumni.

“Black, Hispanic and low-income communities were disproportionately hit by the pandemic,” she said. “Coping with that could have made it really difficult to even get needed care, let alone elective care.”

Advertise with us

She said it will likely take a couple years to see the full consequences of the study’s results. “There could very well be a bump in later-stage cancer diagnoses and even deaths, but we won’t see them right away. It’s really unclear how severe it’s going to be,” she said.

Increasing access to these services shouldn’t stop at the first visit, experts noted. “When we talk about access to screening, it’s not just screening we need to be worried about, but all the resources after,” said Ms. Etzioni. “The remedy is beyond health care. It’s in policies, it’s in Medicaid expansions, and it’s in educating people about their risk. This is one of the biggest problems of our time, and it doesn’t have an easy fix.”

AHN’s free cancer screening clinics have resumed, with the next event at AHN Cancer Institute - Hempfield in Westmoreland County. UPMC Hillman Cancer Center also has resources to help people without insurance get screened.

“We certainly don’t want anyone to not get this potentially life-saving screening because they can’t afford it,” said Ms. Baskin. She said the center is working to increase the availability of at-home screening kits to meet vulnerable populations where they are and reduce the transportation and cost barriers of screenings.

Experts interviewed also called for better screening technologies, such as a potential blood biomarker test, which may increase the ease, and thus the likelihood of patients seeking care.

Advertise with us

Ms. Etzioni said cancer scientists have in the past conducted studies where they increase access to screening services to see if cancer instances decrease. This study, she said, highlighted the opposite: The consequences of decreasing access. “It was a terrible natural experiment,” she said.

Hanna Webster: hwebster@post-gazette.com